Due to the ongoing situation regarding the coronavirus epidemic we have to cancel the 4th Salzburg Breast Cancer Talk 2020, because an event with so many speakers from abroad (Italy, UK, Canada) in October still poses too high a risk and we do not want to implement a virtual solution here.
The event is planned again for 2021 with an identical program.
Further information will follow…
In order of appearanceThe Faculty
Prof. Dr. Richard Greil
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria Dr. Simon P. Gampenrieder
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria Dr. Gabriel Rinnerthaler
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Luca Gianni MD Michelangelo Foundation, Milan, Italy Dr. Iosifina Foskolou Prof. R. Johnson’s Group, Evelyn Trust Patrick Sissons Fellow, Darwin College, Cambridge, United Kingdom; Jonas Söderquists Scholar, Karolinska Institutet, Stockholm, Sweden Prof. Pedro Romero MD Associate Director, Department of Fundamental Oncology, Lausanne University Hospital (CHUV), Faculty of Biology and Medicine, University of Lausanne, Switzerland
Berna Özdemir MD PhD Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland
Onur Boyman MD Professor and Chair of Clinical Immunology, Deputy Dean of Faculty of Medicine, University of Zurich; Director, Department of Immunology, University Hospital Zurich, Switzerland
Prof. Alberto Mantovani MD Humanitas University, Scientific Director, Istituto Clinico Humanitas IRCCS Milan, Italy William Harvey Research Institute, London
Marie-Agnès Doucey PhD MER University of Lausanne and Director & Project Team Leader – Discovery, Ichnos Sciences SA, Lausanne, Switzerland
Dr. Roberto Salgado Department of Pathology, GZA-ZNA Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Karen Willard-Gallo MD PhD Head, Molecular Immunology Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Prof. Dr. Barbara Seliger Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Giuseppe Curigliano MD PhD University of Milan, Director, New Drugs and Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy
Marco Gerlinger MD FRCP Medical Oncologist and Research Group Leader, Translational Oncogenomics Laboratory, Centre for Evolution and Cancer, Institute of Cancer Research, London, United Kingdom
Dr. Laszlo G. Radvanyi PhD President and Scientific Director, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
Dr. John Maher Consultant and Senior Lecturer in Immunology, King’s College London, United Kingdom
Program
Friday, 23. October 2020
12:30 – 13:30 Welcome & Business Lunch
13:30 – 13:35 Introduction Richard Greil, Salzburg
13:35 – 14:25 The clinical point of view
Oxford-style debate: Immunotherapy in breast cancer: failure or magic bullet? Simon Gampenrieder – pro/ Gabriel Rinnerthaler – contra (Salzburg)
Predictive biomarkers in breast cancer immunotherapy trials Luca Gianni (Milan)
14:25 – 15:15 Metabolism and metabolomics
Hypoxia-inducible metabolites shape T cell fate Iosifina Foskolou (Cambridge)
Navigating metabolic pathways to enhance antitumor immunity and immunotherapy Pedro Romero (Lausanne)
15:15 – 15:45 Coffee break
15:45 – 16:35 Influence on immunogenicity … by sex hormones
Berna C. Özdemir (Lausanne) … epigenetic regulation
Onur Boyman (Zurich) 16:35 – 17:30 The innate immune system Innate Immunity , inflammation and cancer: double edged swords
Alberto Mantovani (Milan) Pharmacological re-programming of CD144 pro-metastatic monocytes in human breast cancer
Marie-Agnes Doucey (Lausanne)
17:30 – 18:30 Panel discussion
19:00 Dinner
Saturday, 24. October 2020
08:30 – 10:00 The adaptive immune system
PD-L1 vs. TILs: analytic and diagnostic issues Roberto Salgado (Antwerp) Tertiary lymphoid structures: Phenotypic, genotypic and functional features and their link with the response to cancer immunotherapy Karen Willard-Gallo (Brussels)
MHC class I loss in breast cancer Barbara Seliger (Halle)
10:00 – 10:30 Coffee break
10:30 – 12:10 New treatment strategies
Immunotherapy strategies beyond PD1/PD-L1 inhibition Giuseppe Curigliano (Milan)
Bispecific antibodies in the treatment of solid tumors Marco Gerlinger (London) Adoptive T cell therapy for metastatic melanoma: Lessons learned and implications for breast cancer Laszlo G. Radvanyi (Toronto) CAR T-Cells in breast cancer John Maher (London) 12:10 – 12:55 Panel discussion
Closing Remarks Richard Greil (Salzburg)
13:00 – 14:00 Business Lunch & Farewell
Registration
We look forward to your registration, but we would like to point out that this conference is not open to the public. After your registration your entries will be checked by us, followed by information about your requested participation.
Accreditation by EACCME®
4th SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 8 European CME credits (ECMEC®s).
Venue
Organisation
Prof. Dr. Richard Greil
Dr. Simon P. Gampenrieder
Dr. Gabriel Rinnerthaler
G. Rinnerthaler, C. Quadt, MA Doucey, C. Pozzi, MV Dieci, C. Garlanda, R. Salgado, K. Willard-Gallo, R. Greil, R. Derloo, M. Jalving, RD Kennedy, SP Gampenrieder
Salzburg Breast Cancer Talk 2019
Richard Greil
Salzburg Breast Cancer Talk 2019
Richard Greil
Salzburg Breast Cancer Talk 2019
Regula Derloo decided to stand in for Peter Schmid at short notice. Thanks again!
Salzburg Breast Cancer Talk 2019
Regula Derloo
Salzburg Breast Cancer Talk 2019
Regula Derloo
Salzburg Breast Cancer Talk 2019
Audience at Salzburg Breast Cancer Talk 2019
Salzburg Breast Cancer Talk 2019
Karen Willard-Gallo
Salzburg Breast Cancer Talk 2019
Karen Willard-Gallo
Salzburg Breast Cancer Talk 2019
Karen Willard-Gallo
Salzburg Breast Cancer Talk 2019
Roberto Salgado
Salzburg Breast Cancer Talk 2019
Roberto Salgado
Salzburg Breast Cancer Talk 2019
Roberto Salgado
Salzburg Breast Cancer Talk 2019
Marie-Agnès Doucey
Salzburg Breast Cancer Talk 2019
Marie-Agnès Doucey
Salzburg Breast Cancer Talk 2019
Marie-Agnès Doucey
Salzburg Breast Cancer Talk 2019
Cecilia Garlanda
Salzburg Breast Cancer Talk 2019
Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Salzburg Breast Cancer Talk 2019
Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
Salzburg Breast Cancer Talk 2019
Panel discussion: R.Greil, K. Willard-Gallo, R. Derloo, R. Salgado, MV Dieci, C. Garlanda, MA Doucey
POSTPONED DUE TO SARS-CoV-2 Due to the current situation concerning the coronavirus epidemic and the resulting travel restrictions of even already planned speakers, we have decided to reschedule our event „Salzburg Breast Cancer Talk“ to 2021....
Die Veranstaltung 3rd SALZBURG BREAST CANCER TALK, MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY vom 01. bis 02.03.2019, im PITTER Event Center Salzburg war mit über 100 Teilnehmern wieder ein voller Erfolg. Die Vortragenden, alle auf ihrem Fachgebiet international renommierte Wissenschaftler, verstanden es eindrucksvoll, dem fachkundigen Publikum Einblicke in ihre Forschung am Puls der Zeit zu gewähren. Die Disskusionsrunden […]...
Wir verwenden Cookies, um Ihr Erlebnis auf unserer Website so angenehm wie möglich zu gestalten, um Inhalte und Anzeigen zu personalisieren, Funktionen für soziale Medien anbieten zu können und die Zugriffe auf unsere Website zu analysieren. Außerdem geben wir Informationen zu Ihrer Verwendung unserer Website an unsere Partner für soziale Medien, Werbung und Analysen weiter. Unsere Partner führen diese Informationen möglicherweise mit weiteren Daten zusammen, die Sie ihnen bereitgestellt haben oder die sie im Rahmen Ihrer Nutzung der Dienste gesammelt haben. Mit der weiteren Nutzung der Seite geben Sie die Einwilligung zu unseren Cookies. Weitere Informationen über unsere Datenerfassungspraktiken finden Sie in unserer Datenschutzerklärung.OK